A position paper authored on behalf of the International Osteoporosis Foundation (IOF) Vitamin D Working Group summarizes the burden of vitamin D deficiency and public health approaches for its prevention in global populations, addressing key issues such as global variations in vitamin D concentrations, methodological issues with testing, guidelines, screening, supplementation and food fortification.
SunLive - New Year's Day fall proves life changing - The Bay's News First sunlive.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sunlive.co.nz Daily Mail and Mail on Sunday newspapers.
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Wyost® (denosumab) and Jubbonti® (denosumab) approved by EC for all indications of denosumab reference medicines
Sandoz Receives European Commission Approval for Wyost® and Jubbonti®, the First and Only Biosimilars of Denosumab in Europe koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.